UniProtKB/Swiss-Prot Q16696: Variant p.Val323Leu

• Variant information
• Sequence information
• Literature citations
• All

Variant information

Variant position: 323 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: LB/B The variants are classified into three categories: LP/P, LB/B and US.

• LP/P: likely pathogenic or pathogenic.
• LB/B: likely benign or benign.
• US: uncertain significance

Residue change: From Valine (V) to Leucine (L) at position 323 (V323L, p.Val323Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

• Lowest score: -4 (low probability of substitution).
• Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism: The frequencies of the Cys-257 allele in white, black, Hispanic, and Asian individuals are 1.9%, 14.4%, 5.8%, and 7.7%, respectively. The Cys-257 variant is 37 to 56% less active than the wild-type Arg-257 protein toward all substrates tested. Additional information on the polymorphism described.
Variant description: In allele CYP2A13*9. Any additional useful information about the variant.

Sequence information

Variant position: 323 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 494 The length of the canonical sequence.
Location on the sequence: TETVSTTLRYGFLLLMKHPE V EAKVHEEIDRVIGKNRQPKF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

• Type: the type of sequence feature.
• Positions: endpoints of the sequence feature.
• Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 494	Cytochrome P450 2A13
Helix	321 – 334

Literature citations

Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility.
Cauffiez C.; Lo-Guidice J.-M.; Quaranta S.; Allorge D.; Chevalier D.; Cenee S.; Hamdan R.; Lhermitte M.; Lafitte J.-J.; Libersa C.; Colombel J.-F.; Stuecker I.; Broly F.;
Biochem. Biophys. Res. Commun. 317:662-669(2004)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS GLU-158 AND LEU-323;